An AllTrials project

NCT06149520: An ongoing trial by Bayer

This trial is completed, but has been granted a delay in reporting its results. It must report results 2 years from now.

Full data

Full entry on ClinicalTrials.gov NCT06149520
Title A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of BAY 3018250 in Patients With Symptomatic Proximal Deep Vein Thrombosis
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Jan. 15, 2024
Completion date Oct. 7, 2025
Required reporting date Oct. 7, 2028, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Sept. 24, 2026
Days late None